LTM Q1 FY27: Top line at Rs 11,608 crore, operationally strong show—Key takeaways for investors

​ITR Filing 2026: Penalties, refund delays and consequences of not filing Income Tax Return

Big BIS update! These 4 Indian Standards have changed; check the full list

EPFO Amnesty Scheme 2026 explained: Eligibility, key benefits, deadline and all you need to know

US launches 3rd round of strikes on Iran after alleged attack on commercial ship, says CENTCOM

Ashwini Vaishnaw outlines big AI roadmap for Viksit Bharat 2047, promises stronger compute capacity

Singapore Real Estate: 3 reasons why Indian investors still choose this market despite 60% ABSD

DMart Q1 FY27 Results: At Rs 936 crore, PAT beats estimates; margin in line—Key takeaways

IPOs Next Week: Rs 11,693 crore SBI MF IPO, Alpine Texworld issue to open; key allotments and listings ahead

Trump's big warning to Iran: Claims '1,000 missiles' ready if Iran tries to assassinate him

Jubilant Cadista Pharmaceuticals Inc, is recalling over 1.58 lakh bottles of Pantoprazole Sodium delayed-release tablets manufactured by Jubilant Generics Ltd at its Roorkee plant, from the America and Puerto Rico market, latest report of the US health regulator has said.

 Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Revenue growth to hit 5-year high in Q3: CRISIL Research 

Govt allows 100% FDI under automatic route for single brand retail

Biocon arm widens partnership terms with Bristol-Myers Squibb

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Investor in Martin Shkreli's fund says he made millions

With the GST rollout at the stroke of midnight tonight here is how it will impact your business, industry and even your household finances.

A final check: How GST impacts your toothpaste to your car purchase

Sun Pharma's fourth quarter results have been disappointing. The company said that&nbsp;pricing pressure in its US generic operation will continue for more time. Analysts, in the meantime, have begun downgrading the stock.&nbsp; 
&nbsp;

Sun Pharma shares touch new lows as pricing pressure in US continues 

GV Prasad, Co-Chairman and CEO of Dr Reddy's Laboratories said, “FY17 has been challenging year due to lack of new product approvals for the US market. However, our other geoghraphies delivered good performance with several new product launches.”

 Dr Reddy's Q4 net profit rises by 319% 

"Replacing Obamacare will come with a price for elected representatives who vote to scrap it, say many Americans, who clearly feel their health is in peril under the Republican alternative," CNN quoted Tim Malloy, assistant director of the poll, as saying.

56% disapprove of Republican health care bill: Poll

Glenmark’s current portfolio consists of 112 products authorized for distribution in the US&nbsp;marketplace.

Glenmark receives tentative approval Fingolimod Capsules; shares down

Sun Pharma said, “It's subsidiaries or associate was informed by the US FDA yesterday, that it will lift the import alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the official action initiated (OAI) status."&nbsp;

Sun Pharma shares rise as USFDA clears Mohali facility

Drug firm Lupin today announced the launch of pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.

Lupin launches pain relief drug in US; shares rise

In a BSE filing on Wednesday, Wockhardt said, "The US Food and Drugs Administration (USFDA) has issued a warning letter to Morton Grove Pharmaceuticals, USA, a stepdown subsidiary of the company."

Wockhardt shares tank over 5% after US drug regulator warning 

India`s drug industry is worth about $15 billion and supplies roughly 30 percent of the medicines sold in the United States.

Aurobindo Pharma eyes US plant amid Trump push on jobs

Natco Pharma drops as USFDA makes six observations

The deal is Everstone’s third in the healthcare and wellness sector in less than a year.

Everstone group acquires stake in OmniActive Health for $35 million

pharmaceuticals

150% Dividend Per Share By Pharmaceuticals Company: The pharmaceuticals firm has fixed Friday, July 3, 2026, as the ex-date to determine the eligibility of shareholders for its proposed final dividend. Check details:

50% Final Dividend + 100% Special Dividend: Drug maker to turn ex-date on July 3; do you own?

The India-Oman Comprehensive Economic Partnership Agreement (CEPA) came into force on June 1, providing duty-free access to 99 per cent of Indian exports. The trade pact is expected to boost exports, strengthen trade ties, create jobs and open new opportunities for Indian businesses and professionals in the Gulf region.

India-Oman CEPA comes into force: 99% of Indian exports get duty-free access

India–EU FTA: The India-EU free trade agreement opens access to the $572.3 billion European pharmaceuticals and medical devices market, offering a major boost to Indian drugmakers. The government says the pact will drive exports, job creation, MSME growth and strengthen India’s role as a global pharma hub.

What India-EU free trade agreement means for pharma sector with access to $572.3 billion EU market?

India and Australia marked the third anniversary of their ECTA, showing a significant rise in trade between the two nations. The trade deal, which started three years ago, led to an 8 per cent growth in Indian exports to Australia during the 2024-25 financial year. 

India's export to Australia grows 8% over 3 years of Ind-Aus ECTA: Piyush Goyal

Several Indian pharmaceutical companies including Glenmark, Granules India, Sun Pharma, Zydus and Unichem are recalling medicines from the US market, according to the US Food and Drug Administration (USFDA).

Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA

Zee Business

Home

Personal Finance

India

Economy

Tech

Auto

Markets

Jobs

Indian Railways

World

Videos

Photos

Pharmaceuticals News- Zee Business provides latest news on Pharmaceuticals, Pharmaceuticals news Today, Top News on Pharmaceuticals, update on Pharmaceuticals Stay updated with business news, breaking news headlines.

Pharmaceuticals Latest News- Top News on Pharmaceuticals, Update on Pharmaceuticals, Pharmaceuticals News Today, Breaking News Headlines, Business News | Zee Business

Pharmaceuticals

Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Revenue growth to hit 5-year high in Q3: CRISIL Research

Govt allows 100% FDI under automatic route for single brand retail

Biocon arm widens partnership terms with Bristol-Myers Squibb

Panacea Biotec signs seven drugs deal with Bionpharma Inc

Investor in Martin Shkreli's fund says he made millions

RECOMMENDED

LTM Q1 FY27: Top line at Rs 11,608 crore, operationally strong show—Key takeaways for investors

​ITR Filing 2026: Penalties, refund delays and consequences of not filing Income Tax Return

Big BIS update! These 4 Indian Standards have changed; check the full list

EPFO Amnesty Scheme 2026 explained: Eligibility, key benefits, deadline and all you need to know

US launches 3rd round of strikes on Iran after alleged attack on commercial ship, says CENTCOM

Ashwini Vaishnaw outlines big AI roadmap for Viksit Bharat 2047, promises stronger compute capacity

Singapore Real Estate: 3 reasons why Indian investors still choose this market despite 60% ABSD

DMart Q1 FY27 Results: At Rs 936 crore, PAT beats estimates; margin in line—Key takeaways

IPOs Next Week: Rs 11,693 crore SBI MF IPO, Alpine Texworld issue to open; key allotments and listings ahead

Trump's big warning to Iran: Claims '1,000 missiles' ready if Iran tries to assassinate him

A final check: How GST impacts your toothpaste to your car purchase

Sun Pharma shares touch new lows as pricing pressure in US continues

Dr Reddy's Q4 net profit rises by 319%

56% disapprove of Republican health care bill: Poll

Glenmark receives tentative approval Fingolimod Capsules; shares down

Sun Pharma shares rise as USFDA clears Mohali facility

Lupin launches pain relief drug in US; shares rise

Wockhardt shares tank over 5% after US drug regulator warning

Aurobindo Pharma eyes US plant amid Trump push on jobs

Natco Pharma drops as USFDA makes six observations

Everstone group acquires stake in OmniActive Health for $35 million

Top News

LTM Q1 FY27: Top line at Rs 11,608 crore, operationally strong show—Key takeaways for investors

​ITR Filing 2026: Penalties, refund delays and consequences of not filing Income Tax Return

Big BIS update! These 4 Indian Standards have changed; check the full list

EPFO Amnesty Scheme 2026 explained: Eligibility, key benefits, deadline and all you need to know

US launches 3rd round of strikes on Iran after alleged attack on commercial ship, says CENTCOM

Ashwini Vaishnaw outlines big AI roadmap for Viksit Bharat 2047, promises stronger compute capacity

ITR Filing 2026: Penalties, refund delays and consequences of not filing Income Tax Return

ITR Filing 2026: Penalties, refund delays and consequences of not filing Income Tax Return